坐立肌力与下肢外周动脉疾病患者基线及监督运动训练后功能表现相关
该观察性研究纳入95例Fontaine II期下肢外周动脉疾病患者,在监督运动训练前后评估坐立肌力、最大平板步行距离、功能表现和生活质量。训练后坐立肌力、步行距离、爬梯时间、步速及SF-36各维度均显著改善;基线坐立肌力与基线功能表现及生活质量相关,训练后坐立肌力增加与功能表现改善相关。
要点
- 坐立试验是监测有症状下肢外周动脉疾病患者整体功能状态的有效临床工具。
- 监督运动训练后坐立肌力、最大平板步行距离、6分钟步行距离、爬梯时间、步速及SF-36各维度均显著改善(p < .001)。
- 基线坐立肌力较高与基线功能表现及生活质量较好相关,训练后坐立肌力增加与功能表现改善相关。
核心结论
- 坐立试验是监测有症状下肢外周动脉疾病患者整体功能状态的有效临床工具。
研究设计与样本
- 观察性研究,纳入95例Fontaine II期下肢外周动脉疾病患者,年龄63.1 ± 12.1岁,男性占67%。
- 在监督运动训练前后评估最大平板步行距离、功能表现测试(6分钟步行、坐立试验、爬梯、习惯步速)及生活质量(SF-36问卷),计算相对坐立肌力(W/kg),采用多元回归模型分析。
主要发现
- 相对坐立肌力训练前为2.7 W/kg(95%CI 2.5 - 2.9),训练后为3.3 W/kg(95%CI 3.1 - 3.6)。
- 最大平板步行距离训练前为367.0 m(95%CI 302.4 - 431.5),训练后为598.4 m(95%CI 515.6 - 681.3)。
- 6分钟步行距离训练前为418.3 m(95%CI 399.4 - 437.2),训练后为468.8 m(95%CI 452.7 - 484.9);爬梯时间训练前为6.8秒(95%CI 6.2 - 7.4),训练后为5.3秒(95%CI 4.9 - 5.7);习惯步速训练前为1.10 m/s(95%CI 1.05 - 1.14),训练后为1.18 m/s(95%CI 1.14 - 1.22),均显著增加(p < .001)。
- SF-36躯体成分训练前为31.4(95%CI 29.4 - 33.3),训练后为35.8(95%CI 33.9 - 37.7);心理成分训练前为39.5(95%CI 37.0 - 42.0),训练后为43.1(95%CI 40.9 - 45.4),均显著增加(p < .001)。
- 基线相对坐立肌力较高与基线平板步行表现(β < .380;p < .002)、功能表现(β < .597;p < .001)及生活质量(β < .291;p < .050)较好显著相关;训练后相对坐立肌力增加较大与功能表现改善较大相关(β < .419;p < .009)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with peripheral artery disease (PAD) have decreased muscle power, contributing to functional limitations. The sit to stand (STS) is a validated test to assess muscle power in older individuals; however, it has never been investigated in patients with PAD. The relationship between STS muscle power, and common disease related outcomes was evaluated at baseline and following supervised exercise training (SET) in patients with PAD. METHODS: This observational study investigated patients with Fontaine stage II. Before and after SET, maximum treadmill walking distance (MWD), functional performance tests (six minute walk, STS, stair climbing, habitual gait speed), and quality of life (Short Form 36 questionnaire) were assessed. Relative (W/kg) STS muscle power was calculated using a validated equation. Multiple regressions models were used. RESULTS: Ninety-five patients with PAD were included (63.1 ± 12.1 years, 67% male). Relative STS muscle power before: 2.7 W/kg, 95% confidence interval [CI] 2.5 - 2.9; after: 3.3, 95% CI 3.1 - 3.6, MWD before: 367.0 m, 95% CI 302.4 - 431.5; after: 598.4, 95% CI 515.6 - 681.3, six minute walking distance before: 418.3 metres; 95% CI 399.4 - 437.2; after: 468.8; 95% CI 452.7-484.9, stair climbing performance before: 6.8 seconds 95% CI 6.2 - 7.4); after: 5.3; 95% CI 4.9 - 5.7, habitual gait speed before: 1.10 m/s, 95% CI 1.05 - 1.14; after: 1.18, 95% CI 1.14 - 1.22 increased significantly following SET (p < .001). Similarly, physical before: 31.4, 95% CI 29.4 - 33.3; after: 35.8, 95% CI 33.9 - 37.7 and mental before: 39.5, 95% CI 37.0 - 42.0; after: 43.1, 95% CI 40.9 - 45.4 component summaries of the SF-36 also increased significantly (p < .001). Greater relative STS muscle power at baseline was significantly related to greater baseline treadmill (β < .380; p < .002) and functional (β < .597; p < .001) performance, and quality of life (β < .291; p < .050). Larger increases in relative STS muscle power following SET were associated with greater improvements in functional performance (β < .419; p < .009). CONCLUSION: The STS test is a valid clinical tool to monitor overall functional status in patients with symptomatic PAD.
引用
- Lanzi S, Pousaz A, Calanca L, et al. Sit to Stand Muscle Power Is Related to Functional Performance at Baseline and After Supervised Exercise Training in Patients with Lower Extremity Peripheral Artery Disease. Eur J Vasc Endovasc Surg. 2022. PMID: 36592654. doi:10.1016/j.ejvs.2022.12.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。